Filed: 5/13/2026ACC: 0002104501-26-000008
📋 What this filing means
REMEDIUM CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $319.77M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$319.77M
Total AUM (reported)
8.36M
Total Shares
Allocation by class
COM$319.77M100.0%
Portfolio Concentration
Top 3$241.84M75.6%
4–10$77.92M24.4%
Top 3 weight
75.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 8.36M
Sole
Full voting authority
8.36M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Spyre Therapeutics Inc
SOLEShares1.91M
TypeSH
Market value$96.21M
30.09%
Sole
1.91M
Shared
0.00
None
0.00
Oruka Therapeutics Inc
SOLEShares1.89M
TypeSH
Market value$92.66M
28.98%
Sole
1.89M
Shared
0.00
None
0.00
Damora Therapeutics Inc
SOLEShares2.05M
TypeSH
Market value$52.98M
16.57%
Sole
2.05M
Shared
0.00
None
0.00
Apogee Therapeutics Inc
SOLEShares583.59K
TypeSH
Market value$49.12M
15.36%
Sole
583.59K
Shared
0.00
None
0.00
Jade Biosciences Inc
SOLEShares1.58M
TypeSH
Market value$22.17M
6.93%
Sole
1.58M
Shared
0.00
None
0.00
Crescent Biopharma Inc
SOLEShares361.25K
TypeSH
Market value$6.64M
2.08%
Sole
361.25K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Spyre Therapeutics IncSOLE | COM | 1.91M | SH | $96.21M 30.09% | 1.91M | 0.00 | 0.00 |
Oruka Therapeutics IncSOLE | COM | 1.89M | SH | $92.66M 28.98% | 1.89M | 0.00 | 0.00 |
Damora Therapeutics IncSOLE | COM | 2.05M | SH | $52.98M 16.57% | 2.05M | 0.00 | 0.00 |
Apogee Therapeutics IncSOLE | COM | 583.59K | SH | $49.12M 15.36% | 583.59K | 0.00 | 0.00 |
Jade Biosciences IncSOLE | COM | 1.58M | SH | $22.17M 6.93% | 1.58M | 0.00 | 0.00 |
Crescent Biopharma IncSOLE | COM | 361.25K | SH | $6.64M 2.08% | 361.25K | 0.00 | 0.00 |